Cargando…

A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification

PURPOSE: Patient Specific QA (PSQA) by direct phantom measurement for all intensity modulated radiation therapy (IMRT) cases is labor intensive and an inefficient use of the Medical Physicist's time. The purpose of this work was to develop a hybrid quality assurance (QA) technique utilizing 3D...

Descripción completa

Detalles Bibliográficos
Autores principales: Baltz, Garrett C., Manigold, Remy, Seier, Richard, Kirsner, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018667/
https://www.ncbi.nlm.nih.gov/pubmed/36583305
http://dx.doi.org/10.1002/acm2.13858
_version_ 1784907861465235456
author Baltz, Garrett C.
Manigold, Remy
Seier, Richard
Kirsner, Steven M.
author_facet Baltz, Garrett C.
Manigold, Remy
Seier, Richard
Kirsner, Steven M.
author_sort Baltz, Garrett C.
collection PubMed
description PURPOSE: Patient Specific QA (PSQA) by direct phantom measurement for all intensity modulated radiation therapy (IMRT) cases is labor intensive and an inefficient use of the Medical Physicist's time. The purpose of this work was to develop a hybrid quality assurance (QA) technique utilizing 3D dose verification as a screening tool to determine if a measurement is necessary. METHODS: This study utilized Sun Nuclear DoseCHECK (DC), a 3D secondary verification software, and Fraction 0, a trajectory log IMRT QA software. Twenty‐two Lung stereotactic body radiation therapy (SBRT) and thirty single isocentre multi‐lesion SRS (MLSRS) plans were retrospectively analysed in DC. Agreement of DC and the TPS dose for selected dosimetric criteria was recorded. Calculated 95% confidence limits (CL) were used to establish action limits. All cases were delivered and measured using the Sun Nuclear stereotactic radiosurgery (SRS) MapCheck. Trajectory logs of the delivery were used to calculate Fraction 0 results for the same criteria calculated by DC. Correlation of DC and Fraction 0 results were calculated. Phantom measured QA was compared to Fraction 0 QA results for the cases which had DC criteria action limits exceeded. RESULTS: Correlation of DC and Fraction 0 results were excellent, demonstrating the same action limits could be used for both and DC can predict Fraction 0 results. Based on the calculated action limits, zero lung SBRT cases and six MLSRS cases were identified as requiring a measurement. All plans that passed the DC screening had a passing measurement based PSQA and agreed with Fraction 0 results. CONCLUSION: Using 95% CL action limits of dosimetric criteria, a 3D secondary dose verification can be used to determine if a measurement is required for PSQA. This method is efficient for it is part of the normal clinical workflow when verifying any clinical treatment. In addition, it can drastically reduce the number of measurements needed for PSQA.
format Online
Article
Text
id pubmed-10018667
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100186672023-03-17 A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification Baltz, Garrett C. Manigold, Remy Seier, Richard Kirsner, Steven M. J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Patient Specific QA (PSQA) by direct phantom measurement for all intensity modulated radiation therapy (IMRT) cases is labor intensive and an inefficient use of the Medical Physicist's time. The purpose of this work was to develop a hybrid quality assurance (QA) technique utilizing 3D dose verification as a screening tool to determine if a measurement is necessary. METHODS: This study utilized Sun Nuclear DoseCHECK (DC), a 3D secondary verification software, and Fraction 0, a trajectory log IMRT QA software. Twenty‐two Lung stereotactic body radiation therapy (SBRT) and thirty single isocentre multi‐lesion SRS (MLSRS) plans were retrospectively analysed in DC. Agreement of DC and the TPS dose for selected dosimetric criteria was recorded. Calculated 95% confidence limits (CL) were used to establish action limits. All cases were delivered and measured using the Sun Nuclear stereotactic radiosurgery (SRS) MapCheck. Trajectory logs of the delivery were used to calculate Fraction 0 results for the same criteria calculated by DC. Correlation of DC and Fraction 0 results were calculated. Phantom measured QA was compared to Fraction 0 QA results for the cases which had DC criteria action limits exceeded. RESULTS: Correlation of DC and Fraction 0 results were excellent, demonstrating the same action limits could be used for both and DC can predict Fraction 0 results. Based on the calculated action limits, zero lung SBRT cases and six MLSRS cases were identified as requiring a measurement. All plans that passed the DC screening had a passing measurement based PSQA and agreed with Fraction 0 results. CONCLUSION: Using 95% CL action limits of dosimetric criteria, a 3D secondary dose verification can be used to determine if a measurement is required for PSQA. This method is efficient for it is part of the normal clinical workflow when verifying any clinical treatment. In addition, it can drastically reduce the number of measurements needed for PSQA. John Wiley and Sons Inc. 2022-12-30 /pmc/articles/PMC10018667/ /pubmed/36583305 http://dx.doi.org/10.1002/acm2.13858 Text en © 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Baltz, Garrett C.
Manigold, Remy
Seier, Richard
Kirsner, Steven M.
A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title_full A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title_fullStr A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title_full_unstemmed A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title_short A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification
title_sort hybrid method to improve efficiency of patient specific srs and sbrt qa using 3d secondary dose verification
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018667/
https://www.ncbi.nlm.nih.gov/pubmed/36583305
http://dx.doi.org/10.1002/acm2.13858
work_keys_str_mv AT baltzgarrettc ahybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT manigoldremy ahybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT seierrichard ahybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT kirsnerstevenm ahybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT baltzgarrettc hybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT manigoldremy hybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT seierrichard hybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification
AT kirsnerstevenm hybridmethodtoimproveefficiencyofpatientspecificsrsandsbrtqausing3dsecondarydoseverification